Schulz-Ertner Daniela, Tsujii Hirohiko
Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany.
J Clin Oncol. 2007 Mar 10;25(8):953-64. doi: 10.1200/JCO.2006.09.7816.
Particle beams like protons and heavier ions offer improved dose distributions compared with photon (also called x-ray) beams and thus enable dose escalation within the tumor while sparing normal tissues. Although protons have a biologic effectiveness comparable to photons, ions, because they are heavier than protons, provide a higher biologic effectiveness. Recent technologic developments in the fields of accelerator engineering, treatment planning, beam delivery, and tumor visualization have stimulated the process of transferring particle radiation therapy (RT) from physics laboratories to the clinic. This review describes the physical, biologic, and technologic aspects of particle beam therapy. Clinical trials investigating proton and carbon ion RT will be summarized and discussed in the context of their relevance to recent concepts of treatment with RT.
与光子(也称为X射线)束相比,质子和重离子等粒子束可提供更好的剂量分布,因此能够在肿瘤内提高剂量,同时保护正常组织。虽然质子的生物效应与光子相当,但离子由于比质子重,具有更高的生物效应。加速器工程、治疗计划、束流传输和肿瘤可视化等领域的最新技术发展推动了粒子放射治疗(RT)从物理实验室向临床的转化进程。本综述描述了粒子束治疗的物理、生物和技术方面。将在质子和碳离子RT与RT最新治疗概念相关性的背景下,总结和讨论相关临床试验。